Breast Lesion Localization Methods Market Worth $598 Million by 2024 - Exclusive Report by MarketsandMarkets™

CHICAGO, May 16, 2019 /PRNewswire/ -- According to the new market research report "Breast Lesion Localization Methods Market by Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2024", published by MarketsandMarkets™, the market for Breast Lesion Localization Methods is expected to grow from USD 413 million in 2018 to USD 598 million by 2024, at a CAGR of 6.3% during the forecast period.

Don't miss out on business opportunities in Breast Lesion Localization Methods Market

The overall market for Breast Lesion Localization Methods Market is expected to grow rapidly owing to the increasing number of breast cancer surgeries and increasing awareness on early detection of breast cancer. Furthermore, the demand for improved quality of care and growing awareness among patients about breast cancer screening also contributes to market growth. However, uncertainty in regulatory approval procedures may negatively affect the market. 

Wire localization accounted for the largest share of the Breast Lesion Localization Methods Market in 2018

Based on type, the Breast Lesion Localization Methods Market is divided into wire localization, isotope localization, magnetic localization, electromagnetic localization, and others. The wire localization segment accounted for the largest share of the Breast Lesion Localization Methods Market in 2018. The large share of this segment is attributed to the increasing use of third-party independent quality controls due to their benefits such as longer shelf-lives and flexibility across different reagent lots, which help reduce the cost of operations.

Browse in-depth TOC on "Breast Lesion Localization Methods Market"

67 – Tables

9 – Figures  

103 – Pages

Get 10% Free Customization on this Report: 

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=35768623

The combined localization of non-palpable tumor and sentinel lymph node is expected to grow in the near future

By analyte type, the Breast Lesion Localization Methods Market is segmented into tumor identification and sentinel lymph node identification. The sentinel lymph node identification segment is further divided by types of surgery into lumpectomy and mastectomy. The sentinel lymph node identification segment dominated the Breast Lesion Localization Methods Market in 2018. This segment is expected to grow at the highest rate during the forecast period, mainly due to the increasing acceptance of SLNB as a first-line diagnostic approach for breast cancer staging, as it is more sensitive and causes less morbidity than traditional techniques for the early staging of breast cancer. In addition, the increasing use of combined localization for non-palpable tumors and sentinel lymph nodes such as ROLL and magnetic localization will drive the growth for this segment.

Inquiry Before Buying:

https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=35768623

The APAC market is projected to grow at the highest rate during the forecast period.

In 2018, the Asia Pacific held the largest share of the Breast Lesion Localization Methods Market, in terms of volume. In addition to this, Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The rapidly increasing patient population and healthcare expenditure, improving healthcare infrastructure, high government spending on breast cancer research, and increasing awareness about the importance of the early detection of breast cancer in several APAC countries are supporting the growth of the Asia Pacific Breast Lesion Localization Methods Market.

The prominent players in the Breast Lesion Localization Methods Market are Cianna Medical (US), Endomagnetics Ltd. (UK), and Cook Medical (US), C.R. Bard (US), Intra-Medical Imaging LLC (US), and IsoAid, LLC (US).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/breast-lesion-localization-methods-market.asp
Visit Our Website: https://www.marketsandmarkets.com  

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg